Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma

Authors :: J. Heianna
W. Makino
H. Hirakawa
Y. Yamashita
H. Tomita
S. Murayama
Source :: International Journal of Oral and Maxillofacial Surgery. 51:1123-1130
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.
Abstract: The aim of this study was to evaluate the efficacy of intra-arterial chemoradiotherapy with docetaxel and nedaplatin for T4 maxillary sinus squamous cell carcinoma (MSSCC). Data were retrospectively analysed for 22 consecutive patients with T4 MSSCC who underwent intra-arterial chemoradiotherapy. Participants received intensity-modulated radiotherapy (70 Gy in 35 fractions) concomitantly with docetaxel (60 mg/m

Subjects :: Organoplatinum Compounds
Squamous Cell Carcinoma of Head and Neck
Chemoradiotherapy
Docetaxel
Maxillary Sinus
Otorhinolaryngology
Carcinoma, Squamous Cell
Humans
Infusions, Intra-Arterial
Surgery
Cisplatin
Oral Surgery
Paranasal Sinus Neoplasms
Retrospective Studies

Tools